PeƱonal, Scarlet .
HRN: 24-37-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/09/2024
01/15/2024
IVT
400mg
Q6hrs
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes